Neuralink, the neurotech startup co-founded by Elon Musk, announced Thursday it has received approval from the Food and Drug Administration to conduct its first in-human clinical study.
No BCI company has managed to clinch the FDA's final seal of approval. But by receiving the go-ahead for a study with human patients, Neuralink is one step closer to market.
Neuralink's BCI will require patients to undergo invasive brain surgery. Its system centers around the Link, a small circular implant that processes and translates neural signals. The Link is connected to a series of thin, flexible threads inserted directly into the brain tissue where they detect neural signals.
Patients with Neuralink devices will learn to control it using the Neuralink app. Patients will then be able to control external mice and keyboards through a Bluetooth connection, according to theThe FDA's approval for an in-human study is a significant win for Neuralink after a series of recent hurdles at the company. In February, the U.S.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Elon Musk’s Neuralink gets FDA approval for human test of brain implantsNeuralink is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.
Baca lebih lajut »
Elon Musk's Neuralink gets FDA approval for study of brain implants in humansElon Musk's brain-implant company Neuralink on Thursday said it had received the U.S. Food and Drug Administration's (FDA) approval to launch its first-in-human clinical study.
Baca lebih lajut »
Elon Musk’s brain chip company Neuralink gets FDA approval: What to knowNeuralink said it has regulatory approval to conduct a clinical trial of its brain implants in people, a milestone for the company as it seeks to commercialize a device that will link human brains to computers.
Baca lebih lajut »
Elon Musk's Neuralink says has FDA approval for study of brain implants in humansElon Musk's brain-implant company Neuralink on Thursday said the U.S. Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
Baca lebih lajut »
Elon Musk's brain-implant company Neuralink says it has FDA approval for first human clinical studyElon Musk’s Neuralink said Thursday it has received regulatory approval to start the first in-human clinical study for its brain implant.
Baca lebih lajut »
Elon Musk's Neuralink says it has FDA approval for first human clinical studyNeuralink has been working for years on a brain-computer interface through brain implants.
Baca lebih lajut »